Nedocromil sodium in exercise-induced bronchoconstriction in children

Area of Science:

• Pediatric Pulmonology
• Clinical Pharmacology
• Allergy and Immunology

Background:

• Exercise-induced bronchoconstriction (EIB) is a common condition in asthmatic children.
• Current treatments aim to prevent airway narrowing following physical exertion.
• Nedocromil sodium is an anti-inflammatory agent with potential prophylactic effects.

Purpose of the Study:

• To evaluate the efficacy of nedocromil sodium in preventing exercise-induced bronchoconstriction in pediatric asthma patients.
• To compare nedocromil sodium directly against a placebo within the same patient group.

Main Methods:

• A double-blind, within-patient comparative trial was conducted.
• Twenty children diagnosed with asthma participated.
• Participants received either nedocromil sodium (4 mg) or placebo 30 minutes before an exercise challenge.

Main Results:

• Nedocromil sodium demonstrated statistically significant efficacy in preventing exercise-induced bronchoconstriction compared to placebo.
• The response to exercise challenge was notably improved with nedocromil sodium treatment.
• No unusual or adverse symptoms were reported during the trial.

Conclusions:

• Nedocromil sodium (4 mg) is an effective treatment for exercise-induced bronchoconstriction in children with asthma.
• The drug is well-tolerated, showing a favorable safety profile in this pediatric population.
• These findings support the use of nedocromil sodium as a prophylactic agent for EIB.